Pharmatest Services recently participated in two leading international musculoskeletal research conferences:
- The OARSI World Congress on Osteoarthritis 2026 (West Palm Beach, USA)
- The 53rd European Calcified Tissue Society (ECTS) Congress 2026 (Girona, Spain).
At these events, Pharmatest Services presented the following posters:
- OARSI: KS483 murine mesenchymal progenitor cells as a dual in vitro model for chondrogenic and osteogenic differentiation in drug screening
- ECTS: Establishment of a bone resorption assay using human CD14⁺ monocyte‑derived osteoclasts
The presentations highlight Pharmatest Services’ expertise in advanced in vitro models supporting preclinical and translational research in osteoarthritis and bone health.
Both posters are available for viewing after the conference—reach out to learn more and stay tuned for further updates.